We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

woensdag 28 juni 2017

Nature Reviews Neurology - Table of Contents alert Volume 13 Issue 7

If you are unable to see the message below, click here to view.

Nature Reviews Neurology

Advertisement
Web collection: Parkinson disease 

2017 marks the 200th anniversary since James Parkinson published An Essay on the Shaking Palsy. To mark this event, Nature Reviews Disease Primers, Nature Reviews Neuroscience and Nature Reviews Neurology present this collection of articles about cutting-edge basic and clinical research into Parkinson disease.

Take a look at the collection
 
 
TABLE OF CONTENTS
 
July 2017 Volume 13 Number 7

Nature Reviews Neurology cover
Impact Factor 20.257 Journal Metrics 2-year Median 15
In this issue
Research Highlights
News and Views
Reviews

Also this month
 Featured article:
Imaging and fluid biomarkers in frontotemporal dementia
Lieke H. Meeter, Laura Donker Kaat, Jonathan D. Rohrer & John C. van Swieten




Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
RESEARCH HIGHLIGHTS

Top

Epilepsy: Cannabidiol reduces seizure frequency in Dravet syndrome
Published online: 09 June 2017
p383 | doi:10.1038/nrneurol.2017.86

PDF


In the news: Clinical trials excite at AAN 2017
Published online: 19 May 2017
p384 | doi:10.1038/nrneurol.2017.76

PDF


Dementia: Imaging signatures identified for dementia subtypes
Published online: 19 May 2017
p384 | doi:10.1038/nrneurol.2017.77

PDF


Neurodevelopmental disorders: Metformin — a therapeutic option for fragile X syndrome?
Published online: 02 June 2017
p384 | doi:10.1038/nrneurol.2017.82

PDF


Motor neuron disease: Proinflammatory monocytes might contribute to ALS progression
Published online: 12 May 2017
p385 | doi:10.1038/nrneurol.2017.74

PDF


Cerebrovascular malformations: Microbiota promotes cerebral cavernous malformations
Published online: 26 May 2017
p386 | doi:10.1038/nrneurol.2017.79

PDF


Alzheimer disease: Peripheral Aβ clearance — a therapeutic strategy for AD?
Published online: 26 May 2017
p386 | doi:10.1038/nrneurol.2017.80

PDF


Neurology
JOBS of the week
Assistant / Associate Professor (tenure-track)
McGill University
Faculty Position
Medical University of South Carolina
Massachusetts General Hospital Neurology Department seeking Faculty
Massachusetts General Hospital
Expressions of Interest - Metabolic Disease, Obesity and Type 2 Diabetes Lab Heads / Group Leaders
Monash University
Scientists
Columbia University
More Science jobs from
Neurology
EVENT
International conference on Neurology and Brain Disorders
19.03.18
Valencia, Spain
More science events from
 
NEWS AND VIEWS

Top
Stroke: Long-term outcome of endovascular therapy for ischaemic stroke
Charlotte Zerna & Mayank Goyal
Published online: 02 June 2017
p387 | doi:10.1038/nrneurol.2017.78
In patients with acute ischaemic stroke resulting from anterior circulation occlusion, endovascular therapy provides greater long-term benefits than does intravenous tissue plasminogen activator. However, further improvement of systems of care and research regarding adjunct therapies is still needed.
Full Text | PDF


Epilepsy: A new guideline on sudden unexpected death in epilepsy
Daniel Friedman
Published online: 09 June 2017
p388 | doi:10.1038/nrneurol.2017.83
The American Academy of Neurology and the American Epilepsy Society have jointly issued a new guideline on sudden expected death in epilepsy (SUDEP). The guideline emphasizes the importance of discussing SUDEP with patients and their caregivers, and uncovers gaps in the current literature that warrant further investigation.
Full Text | PDF


Advertisement
Call for nominations: 2017 John Maddox Prize for Standing up for Science.

Recognising the work of individuals who promote science in the face of hostility. Winners will be announced at a reception in London, as well as in Nature, and will receive £2,000.

Closing date for nominations is 31st July 2017.

Click to learn more

 
REVIEWS

Top
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis
Paolo A. Muraro et al.
Published online: 16 June 2017
p391 | doi:10.1038/nrneurol.2017.81
Autologous haematopoietic stem cell transplantation has produced striking results in patients with aggressive multiple sclerosis in small trials. In this Review, Muraro et al. provide an overview of the procedure, detail evidence for its high efficacy in multiple sclerosis, and provide recommendations for its clinical use and future trials.
Abstract | Full Text | PDF


Imaging and fluid biomarkers in frontotemporal dementia
Lieke H. Meeter, Laura Donker Kaat, Jonathan D. Rohrer & John C. van Swieten
Published online: 16 June 2017
p406 | doi:10.1038/nrneurol.2017.75
Reliable biomarkers for frontotemporal dementia (FTD) are required for accurate discrimination between dementia types, prediction of clinical progression and tailoring of pharmacological interventions. This Review discusses the increasing number of available biomarkers for FTD — including novel imaging modalities and fluid biomarkers — and the future challenges in their implementation.
Abstract | Full Text | PDF


Modulators of microglial activation and polarization after intracerebral haemorrhage
Xi Lan et al.
Published online: 19 May 2017
p420 | doi:10.1038/nrneurol.2017.69
Effective drug treatments for intracerebral haemorrhage (ICH) are still lacking. However, therapies that target microglial phenotype switching might soon become available for affected patients. Here, Wang and colleagues summarize key advances in understanding of microglial function after ICH, including modulators of microglial function and interactions with other cells.
Abstract | Full Text | PDF


Drugging the pain epigenome
Ellen Niederberger, Eduard Resch, Michael J. Parnham & Gerd Geisslinger
Published online: 26 May 2017
p434 | doi:10.1038/nrneurol.2017.68
Chronic pain presents a major health burden, affecting more than 20% of adults worldwide, but currently available analgesics lack efficacy and/or are associated with severe adverse effects. Here, Ellen Niederberger and colleagues discuss epigenetic modulation as a new opportunity in pain-relief therapy, and consider the future challenges for the clinical development of these drugs.
Abstract | Full Text | PDF


Advertisement
Nature Awards for Mentoring in Science — Spain

Your mentor could win €10,000

Nominations are now open
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
Nature Reviews Neurology was previously published as Nature Clinical Practice Neurology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature